Response to comment on "the role of naive T cell precursor frequency and recruitment in dictating immune response magnitude"

Journal of Immunology

Volumn 190, Issue 5, 2013, Pages 1896-

  Jenkins, Marc K ^a   Moon, James J ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIBODY; ANTIGEN; BEVACIZUMAB; ERYTHROPOIETIN; ETANERCEPT; HEMOCYANIN; INFLIXIMAB; MELANOMA ANTIGEN 3; NY ESO 1 ANTIGEN; TRASTUZUMAB;

AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSTIMULATION; LETTER; MELANOMA; PRE T LYMPHOCYTE; PRIORITY JOURNAL; SYMPTOMATOLOGY; VACCINATION;

ANIMALS; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS; HUMANS; IMMUNITY, CELLULAR; PEPTIDES; PRECURSOR CELLS, T-LYMPHOID; RECEPTORS, ANTIGEN, T-CELL;

EID: 84874246688     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1290080     Document Type: Letter

References (0)